Organs

Cerevel Therapeutics to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021

Retrieved on: 
Thursday, July 22, 2021
Animal anatomy, Brain, Organs, Life sciences, Biology

CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain totreatneurosciencediseases, today announced it will report second quarter 2021 financial results and provide a pipeline update on Wednesday, August 11, 2021, before the U.S. financial markets open.

Key Points: 
  • CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain totreatneurosciencediseases, today announced it will report second quarter 2021 financial results and provide a pipeline update on Wednesday, August 11, 2021, before the U.S. financial markets open.
  • Management will host a conference call to discuss second quarter 2021 financial results and recent business and pipeline updates on Wednesday, August 11, 2021 at 8:00 a.m. EDT.
  • Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases.
  • Forward-looking statements in this press release include, but are not limited to, statements about the timing of reporting of our second quarter 2021 financial results and the potential attributes and benefits of our product candidates.

Canon Medical Partners with Cleerly to Tackle Heart Disease, the Leading Cause of Death

Retrieved on: 
Friday, July 16, 2021
Oncology, Health, Medical devices, Technology, Other Technology, Radiology, Cardiology, Medicine, Heart diseases, Heart, Organs, Branches of biology, Coronary artery disease, Disease, Articles, Canon Medical Systems USA, Inc., Canon Medical Systems Corporation, Cleerly, CANON MEDICAL SYSTEMS USA, INC., CANON MEDICAL SYSTEMS CORPORATION, CLEERLY

Together, the companies aim to support broader adoption of cardiac CT for the diagnosis and triage of heart disease.

Key Points: 
  • Together, the companies aim to support broader adoption of cardiac CT for the diagnosis and triage of heart disease.
  • In addition, a heart attack or death is often the first symptom of heart disease in more than 50% of individuals diagnosed with coronary artery disease.
  • Once again, Canon has harnessed its strengths and expertise to address pressing healthcare problems, such as heart disease, says Yuji Hamada, president and CEO, Canon Medical Systems, USA.
  • At Canon Medical, we work hand in hand with our partners - our medical, academic and research community.

Researchers Image an Entire Mouse Brain for the First Time

Retrieved on: 
Thursday, July 8, 2021
Health, Medical devices, Other Science, Radiology, Research, Science, Biotechnology, Branches of biology, Biology, Neurophysiology, Nervous system, Animal anatomy, Brain, Organs, Neuroscience

View the full release here: https://www.businesswire.com/news/home/20210708005904/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210708005904/en/
    A team of scientists with Argonne and UChicago visualized an entire mouse brain from synapses on up.
  • Above, a visualization of whole brain interconnectivity, with colors depicting directionality.
  • Using X-ray tomography, researchers were able to image the entire mouse brain roughly one cubic centimeter at the resolution of a micron.
  • But also, the mouse is the workhorse of neuroscience; theyre very useful for analyzing different experimental conditions in the brain.

Study Published in Nature Medicine Shows Investigational NASH Drug Reduced Liver Fat to Normal Levels and Reversed Fibrosis After 16 Weeks of Treatment

Retrieved on: 
Thursday, July 8, 2021
Medical specialties, Clinical medicine, Branches of biology, Hepatology, Liver, Organs, Diabetes, Insulin resistance, Insulin, Organ transplantation, Non-alcoholic fatty liver disease, Cirrhosis

NASH is a serious, potentially life-threatening condition that is a leading cause of liver failure and liver transplantation globally.

Key Points: 
  • NASH is a serious, potentially life-threatening condition that is a leading cause of liver failure and liver transplantation globally.
  • An estimated 17.3 million Americans had NASH in 2016, a number that is expected to increase to 27.0 million by 2030.
  • Weight loss of 10 percent or more has been shown to reverse NASH by restoring normal levels of liver fat and reducing insulin resistance.
  • Reductions in liver fat were associated with substantial decreases in markers of liver injury and fibrosis.

Dermatologist Elizabeth Mullans Shares Summer Skincare Tips for Sensitive Skin

Retrieved on: 
Monday, June 21, 2021
Cosmetics, Retail, Health, Other Health, Fitness & Nutrition, General Health, Skin care, Human skin, Organs, Dermatology, Irritation

Elizabeth Mullans, M.D., Board-Certified Dermatologist at Uptown Dermatology shares her advice on how to help alleviate and avoid skin irritation during the warmer months so people can enjoy their summer blissfully.

Key Points: 
  • Elizabeth Mullans, M.D., Board-Certified Dermatologist at Uptown Dermatology shares her advice on how to help alleviate and avoid skin irritation during the warmer months so people can enjoy their summer blissfully.
  • If you have sensitive skin, it is always a good idea to check the ingredients of the products you are using and avoid skin irritants.
  • Dr. Mullans recommends the following tips for all skin types, especially those with sensitive skin:
    Identify your triggers.
  • Skin sensitivity varies for each person and can be triggered by an ingredient, environmental factors, or a larger skin condition.

Keio University Research: Spotlight on the small intestine and human health

Retrieved on: 
Monday, June 21, 2021
Medical specialties, Anatomy, Gastroenterology, Digestive system, Abdomen, Syndromes, Organs, Small intestine, Gastrointestinal tract, Short bowel syndrome

TOKYO, June 21, 2021 /PRNewswire/ -- Researchers at Keio University, Japan, offer new insights intothe adaptive immune system of the small intestine for new perspectives on host-microorganism symbiosis and organoid-based regeneration of the small intestine for treating short bowel syndrome.

Key Points: 
  • TOKYO, June 21, 2021 /PRNewswire/ -- Researchers at Keio University, Japan, offer new insights intothe adaptive immune system of the small intestine for new perspectives on host-microorganism symbiosis and organoid-based regeneration of the small intestine for treating short bowel syndrome.
  • The Keio Research Highlights website offers more details about this and other recent research being conducted by researchers at Keio University.
  • 10, eabd6480
    In the human body, most of the digestion and absorption of food takes place in the small intestine (small bowel).
  • The latter refers to the highly complex structure of vessels carrying blood and other liquids around within the small intestine.

Keio University Research: Spotlight on the small intestine and human health

Retrieved on: 
Monday, June 21, 2021
Medical specialties, Anatomy, Gastroenterology, Digestive system, Abdomen, Syndromes, Organs, Small intestine, Gastrointestinal tract, Short bowel syndrome

TOKYO, June 21, 2021 /PRNewswire/ -- Researchers at Keio University, Japan, offer new insights intothe adaptive immune system of the small intestine for new perspectives on host-microorganism symbiosis and organoid-based regeneration of the small intestine for treating short bowel syndrome.

Key Points: 
  • TOKYO, June 21, 2021 /PRNewswire/ -- Researchers at Keio University, Japan, offer new insights intothe adaptive immune system of the small intestine for new perspectives on host-microorganism symbiosis and organoid-based regeneration of the small intestine for treating short bowel syndrome.
  • The Keio Research Highlights website offers more details about this and other recent research being conducted by researchers at Keio University.
  • 10, eabd6480
    In the human body, most of the digestion and absorption of food takes place in the small intestine (small bowel).
  • The latter refers to the highly complex structure of vessels carrying blood and other liquids around within the small intestine.

The One Heart Movement to Plant “One Heart Forest” in Loving Memory of All Lives Lost to COVID-19 Throughout the World

Retrieved on: 
Monday, June 7, 2021
General Health, Philanthropy, Other Natural Resources, Infectious diseases, Environment, Forest Products, Parenting, Children, Agriculture, Natural Resources, Fund Raising, Foundation, Family, Other Philanthropy, Consumer, Health, Heart, Organs, Forestry

On World Environment Day, The One Heart Movement announced their plans to plant the One Heart Forest in loving memory of the millions of lives our world has lost to the Covid-19 pandemic.

Key Points: 
  • On World Environment Day, The One Heart Movement announced their plans to plant the One Heart Forest in loving memory of the millions of lives our world has lost to the Covid-19 pandemic.
  • By planting this forest, we celebrate their lives and show our commitment to take care of all life on Earth.
  • The One Heart Movement is inviting everyone to contribute trees to the One Heart Forest.
  • The One Heart Forest is a natural extension of The One Heart Movements ongoing effort to unite and heal hearts globally.

Croma-Pharma Presents New Cosmetic Skincare Brand "Croma farewell™" For Common Skin Conditions

Retrieved on: 
Monday, May 31, 2021
Teens, Women, Family, Health, Cosmetics, Consumer, Pharmaceutical, General Health, Retail, B vitamins, Chemical compounds, Skin care, Hairdressing, Glycosaminoglycans, Human skin, Organs, Panthenol, Facial, Organic compounds, Hyaluronic acid, Niacin

View the full release here: https://www.businesswire.com/news/home/20210531005179/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210531005179/en/
    The Austrian produced brand will initially launch in all key markets with facial serums for five specific skin types.
  • Genetics, external factors and psychological influences can have a decisive impact on an individuals skin condition and lead to various problems.
  • farewell irritated skin: Target-specific face serum for irritated, sensitive skin with Hyaluronic Acid, Madecassoside, Niacinamide and D-Panthenol to sooth irritations, reduce skin redness and strengthen the skin barrier.
  • farewell dry skin: farewell dry skin contains hydrating ingredients including Hyaluronic Acid, Niacinamide, D-Panthenol and Aloe Vera to effectively nourish the skin and strengthen the skin barrier.

NEC's AI Supports Doctors to Detect Neoplasia in Barrett's Esophagus during Endoscopic Procedures

Retrieved on: 
Friday, May 28, 2021
Medical specialties, Gastroenterology, Anatomy, Abdomen, Digestive system, Organs, Barrett's esophagus, Diagnostic gastroenterology, Esophageal cancer, Endoscopy, Esophagus, Stomach

TOKYO, May 28, 2021 - (JCN Newswire) - NEC Corporation (NEC; TSE: 6701) today announced the development of an AI technology for supporting doctors to detect neoplasia in Barrett's esophagus during endoscopic procedures.

Key Points: 
  • TOKYO, May 28, 2021 - (JCN Newswire) - NEC Corporation (NEC; TSE: 6701) today announced the development of an AI technology for supporting doctors to detect neoplasia in Barrett's esophagus during endoscopic procedures.
  • This software is connected to endoscopy processors and automatically notifies users of potential Barrett's neoplasia from images captured during endoscopic procedures.
  • Barrett's esophagus is a pre-cancerous condition in which the inner lining of the esophagus is replaced by a lining that resembles that of the stomach.
  • Patients with Barrett's esophagus have 30-40 fold higher risk of developing cancer of the esophagus as compared to the normal population (4).